Amundi Asset Management US’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$32.7M Buy
607,344
+94,362
+18% +$5.13M 0.03% 533
2020
Q4
$24.7M Sell
512,982
-60,820
-11% -$2.69M 0.02% 574
2020
Q3
$22.5M Buy
573,802
+23,836
+4% +$868K 0.02% 516
2020
Q2
$17.7M Sell
549,966
-122,396
-18% -$4.26M 0.02% 544
2020
Q1
$22.5M Buy
672,362
+46,193
+7% +$1.85M 0.04% 378
2019
Q4
$30M Buy
626,169
+48,125
+8% +$2.33M 0.04% 440
2019
Q3
$28.8M Sell
578,044
-655,293
-53% -$33.4M 0.04% 416
2019
Q2
$70.9M Buy
1,233,337
+31,961
+3% +$1.67M 0.06% 246
2019
Q1
$63.4M Buy
1,201,376
+194,409
+19% +$10.1M 0.09% 231
2018
Q4
$47.3K Buy
1,006,967
+72,044
+8% +$3.76M 0.04% 266
2018
Q3
$53.9M Buy
934,923
+41,176
+5% +$2.28M 0.07% 269
2018
Q2
$48.6M Buy
893,747
+394,907
+79% +$19.6M 0.07% 282
2018
Q1
$23.6M Buy
+498,840
New +$25M 0.04% 434

Other funds holding NTR

Amundi Asset Management US's NTR Position: Q1 2021 in Review

Amundi Asset Management US increased its Nutrien (NTR) stake by 18% in Q1 2021, buying an estimated $5.13M and bringing the position to 607,344 shares worth $32.7M. The position accounts for 0.03% of the portfolio, ranked #533.

Amundi Asset Management US first reported a position in NTR in Q1 2018 and has held it in 13 quarters since. The position peaked at $70.9M in Q2 2019. 550 funds tracked by Wall St. Rank hold NTR as of Q1 2021.

  • Amundi Asset Management US held 607,344 shares of Nutrien worth $32.7M as of Q1 2021.
  • Amundi Asset Management US bought 94,362 Nutrien shares in Q1 2021, an estimated $5.13M.
  • Nutrien made up 0.03% of Amundi Asset Management US's portfolio in Q1 2021, its #533 holding.
  • Amundi Asset Management US first reported a position in Nutrien in Q1 2018 and has held it in 13 quarters since.
  • Amundi Asset Management US's Nutrien position peaked at $70.9M in Q2 2019.
  • 550 funds tracked by Wall St. Rank held Nutrien as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.